ArticleMelanoma research2021

Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218).

F Stephen Hodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.